| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/20/2011 | CN102018709A Tablet capsules with Loratadine tablets and Ambroxol hydrochloride tablets |
| 04/20/2011 | CN102018694A Tablet capsule loaded with salbutamol sulfate tablet and ambroxol hydrochloride tablet |
| 04/20/2011 | CN102018680A Emedastine difumarate sustained release tablets and preparation method thereof |
| 04/20/2011 | CN102018659A Intestine positioning preparation of glycyrrhetic acid, glycyrrhetinic acid and salts of glycyrrhetic acid and glycyrrhetinic acid, and preparation method and application thereof |
| 04/20/2011 | CN101732584B Throat disinhibiting bagged soaking preparation for treating pharyngitis |
| 04/20/2011 | CN101647776B Doxofylline venous injection with small volume as well as preparation method and quality control method thereof |
| 04/20/2011 | CN101612178B Carrot seed volatile oil preparation method and application thereof |
| 04/20/2011 | CN101564461B Method for preparing Chinese medicine used for clearing heat, moistening lung, relieving cough, resolving phlegm, disinhibiting urine and freeing strangury |
| 04/20/2011 | CN101530618B Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma |
| 04/20/2011 | CN101474395B Method for preparing Chinese medicine for treating children's exterior cold and interior heat type asthma symptoms |
| 04/20/2011 | CN101407743B Method for extracting and separating curcuma oil |
| 04/20/2011 | CN101396522B Medicine for treating pharyngitis |
| 04/20/2011 | CN101390984B Detection method of Lanhuayao |
| 04/20/2011 | CN101301463B Chinese medicinal composition for treating chronic purulent nasosinusitis and chronic rhinitis |
| 04/20/2011 | CN101292687B Olive health-care tea and its preparing process |
| 04/20/2011 | CN101269143B Method for preparing Fupoganmao particle and prepared product |
| 04/20/2011 | CN101264247B 'Lulian' anti-inflammation pill and preparation thereof |
| 04/20/2011 | CN101263921B Preparation of olive health care beverage |
| 04/20/2011 | CN101254305B Composite nasal cavity preparations for curing allergic rhinitis |
| 04/20/2011 | CN101224259B Detection method of compound south isatis root granules |
| 04/20/2011 | CN101204510B Preparation and detection method of Chinese traditional medicine preparation |
| 04/20/2011 | CN101199534B Anti-tumor function of raw panoxadiol derivative |
| 04/20/2011 | CN101185707B Antiphlogistic antiviral medicinal composition, and its preparation method and application |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/20/2011 | CN101095827B Chinese traditional medicine preparations for treating laryngopharynx disease and method for preparing the same |
| 04/20/2011 | CN101036710B Oral preparation for treating chough and its preparing process |
| 04/20/2011 | CN101028510B Snake gallbladder for artificial medicine and its production |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928089 Mucoactive agents for treating a pulmonary disease |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2507572C Levalbuterol salt |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043359A1 Pharmaceutical product containing aromatic heterocyclic compound |
| 04/14/2011 | WO2011042469A1 Use of a compound based on eremophilanolides |
| 04/14/2011 | WO2011021203A3 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 04/14/2011 | WO2010143919A3 Method and composition for preventing or treating il-6-mediated diseases or rhinovirus infections |
| 04/14/2011 | WO2010138862A3 Compositions for respiratory delivery of active agents and associated methods and systems |
| 04/14/2011 | US20110086896 Crystalline and Stable Form of Andolast |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086881 Crystalline forms of a dimethylphenyl compound |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086827 Combination medicament |
| 04/14/2011 | US20110086796 Methods for predicting the development and resolution of acute respiratory distress syndrome |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086114 Nasal composition |
| 04/14/2011 | US20110086101 Dispersinb, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K-Based Antibiofilm Compositions and Uses Thereof |
| 04/14/2011 | US20110086072 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/14/2011 | US20110086052 Activation of innate and adaptive immune responses by a ginseng extract |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086026 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 04/14/2011 | US20110086023 Combination antihistamine medication |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308879A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors |
| 04/13/2011 | EP2308491A1 Pirfenidone therapy and inducers of cytochrome P450 |
| 04/13/2011 | EP2308489A1 Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock |
| 04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
| 04/13/2011 | EP2307383A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307378A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307377A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307362A2 Antagonists of prostaglandin d2 receptors |
| 04/13/2011 | EP2307046A2 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/13/2011 | EP2307034A2 Extract of coptidis rhizoma and novel use thereof in treating resupiratory disease |
| 04/13/2011 | EP2307004A1 Novel treatments |
| 04/13/2011 | EP2306843A1 Nutritional composition for infants delivered via caesarean section |
| 04/13/2011 | EP2125744B1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 04/13/2011 | EP2051714B1 Drug combinations for the treatment of respiratory tract diseases |
| 04/13/2011 | EP2018165B1 Fgf-peceptor agonist dimeric compounds |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | EP1438026B1 Taste masking spill-resistant formulation |